Table 2 Patient demographics, comorbidities, and outcomes
Energy mechanism | P value | ||
|---|---|---|---|
Low (n = 98) | High (n = 25) | ||
Age (SD)1 | 32.4 (12.6) | 4.9 (13.1) | 0.489 |
Number of males (%)2 | 87 (88.8) | 19 (76.1) | 0.18 |
History of osteoporosis (%)2 | 0/97 (0) | 0 (0) | NA |
Pre-injury steroid use (%)2 | 1/97 (1) | 0 (0) | 1 |
Pre-injury tobacco use (%)2 | 26/97 (27) | 5 (20) | 0.661 |
Pre-injury anticoagulant use (%)2 | 0 (0) | 2 (8) | 0.053 |
Calcium levels (SD)1 | 9.0 (0.7), n = 95 | 9.0 (0.6) | 0.819 |
Albumin levels (SD)1 | 4.3 (0.4), n = 95 | 4.3 (0.7) | 0.211 |
Positive ethanol (%)2 | 44/82 (54) | 5/24 (22) | 0.012* |
Hospital LOS—days (SD)1 | 4 (4), n = 67 | 14 (12), n = 23 | < 0.001* |
ICU LOS—days (SD)1 | 4 (3), n = 13 | 12 (10), n = 15 | 0.011* |
ICU admittance (%)2 | 13 (13) | 15 (60) | < 0.001* |
Needing ventilator (%)2 | 8 (8) | 12 (48) | < 0.001* |
Days on ventilator (SD)1 | 4.7 (6.5) | 10.7 (7.7) | 0.081 |
ISS (SD)1 | 7.5 (6.3) | 16.8 (9.8) | < 0.001* |
GCS (SD)1 | 14.2 (2.1) | 11.7 (4.2) | 0.002* |
Mortality (%)2 | 1 (1) | 1 (4) | 0.367 |